Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Berthet

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
Breast Cancer Research : BCR|June 20, 2023
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort ConsortiumKarin Kast, Esther M John, John L Hopper, et al.
JNCI Cancer Spectrum|July 31, 2019
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort StudyLieske H Schrijver, Håkan Olsson, Kelly-Anne Phillips, et al.
International Journal of Cancer|October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testingElodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
BMC Cancer|January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancerOlga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
JAMA|June 21, 2017
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, John L Hopper, Daniel R Barnes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Nature|October 21, 2011
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaCorine Bertolotto, Fabienne Lesueur, Sandy Giuliano, et al.
Breast Cancer Research : BCR|November 13, 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 womenTimothy R Rebbeck, Tara M Friebel, Nandita Mitra, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 4, 2019
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from The BRCA1 and BRCA2 Cohort ConsortiumHongyan Li, Mary Beth Terry, Antonis C Antoniou, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the diseaseYue Jiao, Thérèse Truong, Séverine Eon-Marchais, et al.
Breast Cancer Research : BCR|June 20, 2023
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort ConsortiumKarin Kast, Esther M John, John L Hopper, et al.
JNCI Cancer Spectrum|July 31, 2019
Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort StudyLieske H Schrijver, Håkan Olsson, Kelly-Anne Phillips, et al.
International Journal of Cancer|October 11, 2018
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testingElodie Girard, Séverine Eon-Marchais, Robert Olaso, et al.
BMC Cancer|January 14, 2016
GENESIS: a French national resource to study the missing heritability of breast cancerOlga M Sinilnikova, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
JAMA|June 21, 2017
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, John L Hopper, Daniel R Barnes, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyFergus J Couch, Olga Sinilnikova, Robert A Vierkant, et al.
Nature|October 21, 2011
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinomaCorine Bertolotto, Fabienne Lesueur, Sandy Giuliano, et al.
Breast Cancer Research : BCR|November 13, 2016
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 womenTimothy R Rebbeck, Tara M Friebel, Nandita Mitra, et al.
Pageof 8